Edmond DE Rothschild Holding S.A. Has $4.80 Million Stock Position in Agilent Technologies, Inc. $A

Edmond DE Rothschild Holding S.A. grew its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 7.8% during the second quarter, Holdings Channel reports. The firm owned 40,657 shares of the medical research company’s stock after purchasing an additional 2,958 shares during the period. Edmond DE Rothschild Holding S.A.’s holdings in Agilent Technologies were worth $4,798,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Resona Asset Management Co. Ltd. increased its holdings in shares of Agilent Technologies by 6.2% during the 2nd quarter. Resona Asset Management Co. Ltd. now owns 98,400 shares of the medical research company’s stock valued at $11,631,000 after acquiring an additional 5,767 shares during the last quarter. TrueMark Investments LLC acquired a new stake in Agilent Technologies in the 2nd quarter worth approximately $1,999,000. Fenimore Asset Management Inc boosted its position in Agilent Technologies by 2.7% during the second quarter. Fenimore Asset Management Inc now owns 180,880 shares of the medical research company’s stock worth $21,346,000 after purchasing an additional 4,823 shares during the period. Nuance Investments LLC grew its holdings in Agilent Technologies by 13.5% during the second quarter. Nuance Investments LLC now owns 80,698 shares of the medical research company’s stock valued at $9,523,000 after purchasing an additional 9,628 shares during the last quarter. Finally, Asset Management One Co. Ltd. grew its holdings in Agilent Technologies by 3.4% during the second quarter. Asset Management One Co. Ltd. now owns 124,577 shares of the medical research company’s stock valued at $14,701,000 after purchasing an additional 4,152 shares during the last quarter. Institutional investors and hedge funds own 87.41% of the company’s stock.

Agilent Technologies Price Performance

Shares of A opened at $157.25 on Wednesday. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53. The stock has a market cap of $44.58 billion, a P/E ratio of 36.91, a price-to-earnings-growth ratio of 4.67 and a beta of 1.29. The stock’s 50-day moving average price is $140.80 and its two-hundred day moving average price is $126.03. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $160.27.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, topping the consensus estimate of $1.58 by $0.01. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The business had revenue of $1.86 billion for the quarter, compared to analyst estimates of $1.83 billion. During the same quarter last year, the firm earned $1.46 EPS. Agilent Technologies’s quarterly revenue was up 9.4% compared to the same quarter last year. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS. FY 2026 guidance at 5.860-6.000 EPS. On average, equities analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 28th. Investors of record on Tuesday, January 6th will be given a $0.255 dividend. The ex-dividend date is Tuesday, January 6th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.6%. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.25. Agilent Technologies’s dividend payout ratio is currently 23.94%.

Analysts Set New Price Targets

Several analysts recently issued reports on the stock. Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Friday, October 3rd. UBS Group upped their price target on shares of Agilent Technologies from $170.00 to $180.00 and gave the company a “buy” rating in a report on Tuesday. Evercore ISI lifted their price objective on Agilent Technologies from $128.00 to $140.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 7th. Wells Fargo & Company raised their target price on Agilent Technologies from $150.00 to $175.00 and gave the company an “overweight” rating in a report on Tuesday. Finally, Barclays upped their price target on Agilent Technologies from $145.00 to $165.00 and gave the stock an “equal weight” rating in a report on Tuesday. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $161.08.

Insider Activity at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 911 shares of Agilent Technologies stock in a transaction dated Tuesday, November 18th. The stock was sold at an average price of $143.24, for a total transaction of $130,491.64. Following the transaction, the chief executive officer owned 32,058 shares in the company, valued at $4,591,987.92. The trade was a 2.76% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.26% of the stock is currently owned by corporate insiders.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.